Application of Big Data Technology for COVID-19 Prevention and Control in China: Lessons and Recommendations.


Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
09 10 2020
Historique:
received: 30 06 2020
accepted: 14 09 2020
revised: 28 07 2020
pubmed: 2 10 2020
medline: 27 10 2020
entrez: 1 10 2020
Statut: epublish

Résumé

In the prevention and control of infectious diseases, previous research on the application of big data technology has mainly focused on the early warning and early monitoring of infectious diseases. Although the application of big data technology for COVID-19 warning and monitoring remain important tasks, prevention of the disease's rapid spread and reduction of its impact on society are currently the most pressing challenges for the application of big data technology during the COVID-19 pandemic. After the outbreak of COVID-19 in Wuhan, the Chinese government and nongovernmental organizations actively used big data technology to prevent, contain, and control the spread of COVID-19. The aim of this study is to discuss the application of big data technology to prevent, contain, and control COVID-19 in China; draw lessons; and make recommendations. We discuss the data collection methods and key data information that existed in China before the outbreak of COVID-19 and how these data contributed to the prevention and control of COVID-19. Next, we discuss China's new data collection methods and new information assembled after the outbreak of COVID-19. Based on the data and information collected in China, we analyzed the application of big data technology from the perspectives of data sources, data application logic, data application level, and application results. In addition, we analyzed the issues, challenges, and responses encountered by China in the application of big data technology from four perspectives: data access, data use, data sharing, and data protection. Suggestions for improvements are made for data collection, data circulation, data innovation, and data security to help understand China's response to the epidemic and to provide lessons for other countries' prevention and control of COVID-19. In the process of the prevention and control of COVID-19 in China, big data technology has played an important role in personal tracking, surveillance and early warning, tracking of the virus's sources, drug screening, medical treatment, resource allocation, and production recovery. The data used included location and travel data, medical and health data, news media data, government data, online consumption data, data collected by intelligent equipment, and epidemic prevention data. We identified a number of big data problems including low efficiency of data collection, difficulty in guaranteeing data quality, low efficiency of data use, lack of timely data sharing, and data privacy protection issues. To address these problems, we suggest unified data collection standards, innovative use of data, accelerated exchange and circulation of data, and a detailed and rigorous data protection system. China has used big data technology to prevent and control COVID-19 in a timely manner. To prevent and control infectious diseases, countries must collect, clean, and integrate data from a wide range of sources; use big data technology to analyze a wide range of big data; create platforms for data analyses and sharing; and address privacy issues in the collection and use of big data.

Sections du résumé

BACKGROUND
In the prevention and control of infectious diseases, previous research on the application of big data technology has mainly focused on the early warning and early monitoring of infectious diseases. Although the application of big data technology for COVID-19 warning and monitoring remain important tasks, prevention of the disease's rapid spread and reduction of its impact on society are currently the most pressing challenges for the application of big data technology during the COVID-19 pandemic. After the outbreak of COVID-19 in Wuhan, the Chinese government and nongovernmental organizations actively used big data technology to prevent, contain, and control the spread of COVID-19.
OBJECTIVE
The aim of this study is to discuss the application of big data technology to prevent, contain, and control COVID-19 in China; draw lessons; and make recommendations.
METHODS
We discuss the data collection methods and key data information that existed in China before the outbreak of COVID-19 and how these data contributed to the prevention and control of COVID-19. Next, we discuss China's new data collection methods and new information assembled after the outbreak of COVID-19. Based on the data and information collected in China, we analyzed the application of big data technology from the perspectives of data sources, data application logic, data application level, and application results. In addition, we analyzed the issues, challenges, and responses encountered by China in the application of big data technology from four perspectives: data access, data use, data sharing, and data protection. Suggestions for improvements are made for data collection, data circulation, data innovation, and data security to help understand China's response to the epidemic and to provide lessons for other countries' prevention and control of COVID-19.
RESULTS
In the process of the prevention and control of COVID-19 in China, big data technology has played an important role in personal tracking, surveillance and early warning, tracking of the virus's sources, drug screening, medical treatment, resource allocation, and production recovery. The data used included location and travel data, medical and health data, news media data, government data, online consumption data, data collected by intelligent equipment, and epidemic prevention data. We identified a number of big data problems including low efficiency of data collection, difficulty in guaranteeing data quality, low efficiency of data use, lack of timely data sharing, and data privacy protection issues. To address these problems, we suggest unified data collection standards, innovative use of data, accelerated exchange and circulation of data, and a detailed and rigorous data protection system.
CONCLUSIONS
China has used big data technology to prevent and control COVID-19 in a timely manner. To prevent and control infectious diseases, countries must collect, clean, and integrate data from a wide range of sources; use big data technology to analyze a wide range of big data; create platforms for data analyses and sharing; and address privacy issues in the collection and use of big data.

Identifiants

pubmed: 33001836
pii: v22i10e21980
doi: 10.2196/21980
pmc: PMC7561444
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e21980

Informations de copyright

©Jun Wu, Jian Wang, Stephen Nicholas, Elizabeth Maitland, Qiuyan Fan. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 09.10.2020.

Références

PLoS One. 2009 Aug 24;4(8):e6671
pubmed: 19701458
Sci Rep. 2015 Aug 03;5:12760
pubmed: 26234783
J Infect Dis. 2016 Dec 1;214(suppl_4):S399-S403
pubmed: 28830106
PLoS One. 2011 Feb 11;6(2):e16796
pubmed: 21347303
Sci Rep. 2018 Feb 21;8(1):3395
pubmed: 29467373
Travel Med Infect Dis. 2020 Jan - Feb;33:101568
pubmed: 32006656
J Integr Med. 2020 Mar;18(2):152-158
pubmed: 32113846
J Infect Dis. 2016 Dec 1;214(suppl_4):S393-S398
pubmed: 28830108
JMIR Public Health Surveill. 2020 Apr 14;6(2):e18828
pubmed: 32234709
PLoS One. 2016 Jul 25;11(7):e0157734
pubmed: 27455108
Sci Rep. 2017 Sep 5;7(1):10437
pubmed: 28874880
J Thorac Dis. 2020 Mar;12(3):165-174
pubmed: 32274081
PLoS One. 2017 May 2;12(5):e0176690
pubmed: 28464015
J Infect Dis. 2016 Dec 1;214(suppl_4):S421-S426
pubmed: 28830110
Int J Environ Res Public Health. 2020 May 02;17(9):
pubmed: 32370204
World J Otorhinolaryngol Head Neck Surg. 2020 May 19;:
pubmed: 32837757
PLoS One. 2013;8(2):e56176
pubmed: 23457520
Sci Rep. 2016 Dec 20;6:38522
pubmed: 27994231
PLoS One. 2013 Dec 05;8(12):e81422
pubmed: 24339927
Int J Environ Res Public Health. 2020 Mar 31;17(7):
pubmed: 32244425
PLoS One. 2017 Jan 6;12(1):e0165085
pubmed: 28060809
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
Indian J Orthop. 2020 May 7;:1-3
pubmed: 32382166
Philos Technol. 2019;32(1):69-85
pubmed: 31024785
J Infect Dis. 2016 Dec 1;214(suppl_4):S386-S392
pubmed: 28830105
J Travel Med. 2020 Aug 20;27(5):
pubmed: 32437541
Health Inf Sci Syst. 2014 Feb 07;2:3
pubmed: 25825667
Int J Environ Res Public Health. 2018 Jul 27;15(8):
pubmed: 30060525
J Infect Dis. 2016 Dec 1;214(suppl_4):S375-S379
pubmed: 28830113
Comput Biol Med. 2020 Jun;121:103805
pubmed: 32568679
PLoS One. 2013 Dec 13;8(12):e81887
pubmed: 24349148
Nature. 2009 Feb 19;457(7232):1012-4
pubmed: 19020500
Eur Respir J. 2020 Aug 6;56(2):
pubmed: 32444412
Am J Bioeth. 2013;13(4):40-2
pubmed: 23514395
PLoS One. 2015 Mar 02;10(3):e0117296
pubmed: 25729897
J Pathol Inform. 2016 Jul 26;7:29
pubmed: 27563488
J Infect Dis. 2016 Dec 1;214(suppl_4):S380-S385
pubmed: 28830112
Int J Surg. 2020 Aug;80:21-25
pubmed: 32590073

Auteurs

Jun Wu (J)

Dong Fureng Institute of Economic and Social Development, Wuhan University, Wuhan, China.

Jian Wang (J)

Dong Fureng Institute of Economic and Social Development, Wuhan University, Beijing, China.

Stephen Nicholas (S)

Australian National Institute of Management and Commerce, Sydney, Australia.
Newcastle Business School, University of Newcastle, Newcastle, Australia.

Elizabeth Maitland (E)

School of Management, University of Liverpool, Liverpool, United Kingdom.

Qiuyan Fan (Q)

Dong Fureng Institute of Economic and Social Development, Wuhan University, Wuhan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH